Liquidity ratios measure the company ability to meet its short-term obligations.
Paying user area
Try for free
HCA Healthcare Inc. pages available for free this week:
- Income Statement
- Statement of Comprehensive Income
- Balance Sheet: Liabilities and Stockholders’ Equity
- Cash Flow Statement
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Solvency Ratios
- Common Stock Valuation Ratios
- Present Value of Free Cash Flow to Equity (FCFE)
- Net Profit Margin since 2011
- Return on Equity (ROE) since 2011
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to HCA Healthcare Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Liquidity Ratios (Summary)
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).
The liquidity ratios over the observed periods illustrate varied trends in the company's short-term financial health and its ability to meet obligations.
- Current Ratio
- The current ratio shows moderate fluctuations ranging mostly between 1.05 and 1.61. Initially, it was relatively stable around 1.35 to 1.61 in 2018, with a dip to 1.05 in March 2019. Afterward, it improved and stabilized around 1.4 to 1.5 during 2019. There was a notable decline in mid-2020 dropping close to 1.09, likely reflecting stress during that period, but it recovered again towards the end of 2020 and remained steady near 1.4 through early 2022. This indicates a consistent ability to cover current liabilities with current assets, maintaining a ratio generally above 1, which is a positive sign of liquidity.
- Quick Ratio
- The quick ratio follows a pattern similar to the current ratio but is consistently lower, as expected given it excludes inventories. This ratio ranged from a low of 0.76 in March 2019 to a high near 1.14 in September 2018. There are fluctuations corresponding to those in the current ratio; a drop during early 2019 is visible, followed by recovery and moderate volatility through 2020 and 2021. The ratio hovers close to or slightly above 1 from late 2019 onward, signaling that liquid assets (excluding inventories) are generally sufficient to meet short-term liabilities. The brief decline during mid-2020 is consistent with broader liquidity challenges experienced in that period.
- Cash Ratio
- The cash ratio exhibits the greatest volatility among the three measures, with very low values in early years (around 0.05-0.15) and substantial spikes notably in June and September 2020, where it rose to 0.36 and 0.46 respectively. This dramatic increase in cash and cash equivalents relative to current liabilities suggests either a build-up of cash reserves or lower short-term liabilities during that time. Subsequently, the ratio decreased but remained at elevated levels compared to earlier years, staying between 0.11 and 0.23 from 2021 into 2022. This trend indicates a strategic shift or response to uncertain conditions by maintaining higher cash liquidity, providing greater immediate solvency.
Overall, the analysis of liquidity ratios points to a company that generally maintains acceptable short-term financial stability, with occasional liquidity tightening notably in early to mid-2019 and mid-2020. The substantial increase in the cash ratio during 2020 may reflect a cautious approach in response to market or operational uncertainties during that period. Both the current and quick ratios consistently support the company’s ability to manage its current obligations effectively.
Current Ratio
| Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||
| Current assets | |||||||||||||||||||||||
| Current liabilities | |||||||||||||||||||||||
| Liquidity Ratio | |||||||||||||||||||||||
| Current ratio1 | |||||||||||||||||||||||
| Benchmarks | |||||||||||||||||||||||
| Current Ratio, Competitors2 | |||||||||||||||||||||||
| Abbott Laboratories | |||||||||||||||||||||||
| Elevance Health Inc. | |||||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||||
| UnitedHealth Group Inc. | |||||||||||||||||||||||
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).
1 Q1 2022 Calculation
Current ratio = Current assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
The analysis of the quarterly financial data reveals several notable trends concerning liquidity and short-term financial stability.
- Current Assets
- The current assets demonstrate an overall upward trend from March 2018 through March 2022, increasing from approximately $10.4 billion to $15.0 billion. This growth, however, exhibits some volatility, with notable peaks in June and September 2020, reaching levels above $16 billion before declining significantly at year-end 2020. Post-2020, current assets steadily rose again, suggesting periods of strategic asset management or operational shifts impacting the asset base.
- Current Liabilities
- Current liabilities fluctuate considerably across the periods. Starting at about $7.5 billion in early 2018, liabilities show substantial increases in March 2019 and mid-2020, reaching over $14 billion in September 2020. Following this peak, liabilities sharply decrease by December 2020, settling around $8.7 billion, and gradually increase again toward early 2022. The pronounced spikes in liabilities during 2019 and especially 2020 could indicate elevated short-term obligations or operational pressures during those intervals.
- Current Ratio
- The current ratio, reflecting the company's ability to cover short-term liabilities with current assets, fluctuates between approximately 1.05 and 1.61 over the observed period. Notably, it dips to its lowest at slightly above 1.0 in March 2019 and June 2020, suggesting tighter liquidity during these specific quarters. Conversely, the ratio peaks above 1.6 in September 2018 and March 2020, indicating relatively stronger liquidity positions at those times. For most periods, the current ratio remains above 1.3, implying a generally satisfactory position in managing current liabilities via available assets.
In summary, the data indicates that the company manages its liquidity with some variability, facing periods of higher short-term liabilities offset by increases in current assets. The fluctuations in the current ratio highlight intervals of both tighter and more comfortable liquidity positions, but the consistent maintenance of a ratio above 1.0 suggests ongoing capability to meet short-term obligations. The substantial spikes in current liabilities and concurrent changes in current assets around 2020 point to possible operational or market influences impacting the financial structure during that year.
Quick Ratio
| Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||||||
| Accounts receivable | |||||||||||||||||||||||
| Total quick assets | |||||||||||||||||||||||
| Current liabilities | |||||||||||||||||||||||
| Liquidity Ratio | |||||||||||||||||||||||
| Quick ratio1 | |||||||||||||||||||||||
| Benchmarks | |||||||||||||||||||||||
| Quick Ratio, Competitors2 | |||||||||||||||||||||||
| Abbott Laboratories | |||||||||||||||||||||||
| Elevance Health Inc. | |||||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||||
| UnitedHealth Group Inc. | |||||||||||||||||||||||
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).
1 Q1 2022 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
- Quick Assets Trend
- The total quick assets experienced fluctuations over the observed periods. Beginning at approximately $7.4 billion in the first quarter of 2018, the value showed a slight decline by the end of 2018, dropping to around $7.3 billion. A notable increase was observed in mid-2019, peaking near $9.6 billion in June 2019, followed by a decrease toward the end of the same year. The year 2020 witnessed significant volatility, with quick assets rising sharply to over $13 billion by the third quarter before dropping below $9 billion by year-end. In 2021 and early 2022, the quick assets generally stabilized, maintaining values between $8.5 billion and $10.9 billion.
- Current Liabilities Trend
- Current liabilities showed marked variability throughout the periods. Starting close to $7.5 billion in the first quarter of 2018, liabilities increased notably in the first quarter of 2019, reaching over $10.5 billion. Mid-2019 to the end of 2019 saw a decline to around $7.1 billion, followed by a sharp increase in mid-2020, peaking at almost $14.4 billion in the third quarter. This was succeeded by a steep reduction by year-end 2020 to about $8.7 billion. From 2021 onward, current liabilities remained relatively consistent, ranging from approximately $8.6 billion to $10.5 billion.
- Quick Ratio Analysis
- The quick ratio exhibited significant variation across the quarters, reflecting fluctuating liquidity conditions. The ratio hovered near parity (close to 1.0) in 2018, with a low of 0.76 in the first quarter of 2019 indicating lower liquidity relative to liabilities. Subsequently, the ratio improved and stabilized around 1.0 until early 2020, suggesting adequate short-term liquidity. However, in mid-2020, the quick ratio declined sharply to a low of 0.84, reflecting increased liabilities relative to quick assets. This was followed by a gradual recovery towards the end of 2020 and sustained levels around 1.0 throughout 2021 and into early 2022.
- Overall Insights
- Over the entire span, the financial data indicates that the company managed liquidity with some periods of strain, particularly in early 2019 and mid-2020 where the quick ratio dipped below 1.0. The sharp increases in both quick assets and current liabilities in mid-2020 likely correlate with external factors influencing operational cash flows and short-term obligations. The recovery and stabilization of the quick ratio in subsequent periods suggest effective management efforts towards maintaining short-term financial stability.
Cash Ratio
| Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||||||
| Total cash assets | |||||||||||||||||||||||
| Current liabilities | |||||||||||||||||||||||
| Liquidity Ratio | |||||||||||||||||||||||
| Cash ratio1 | |||||||||||||||||||||||
| Benchmarks | |||||||||||||||||||||||
| Cash Ratio, Competitors2 | |||||||||||||||||||||||
| Abbott Laboratories | |||||||||||||||||||||||
| Elevance Health Inc. | |||||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||||
| UnitedHealth Group Inc. | |||||||||||||||||||||||
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).
1 Q1 2022 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
The quarterly financial data reveals significant fluctuations in the key liquidity indicators over the observed periods.
- Total Cash Assets
- Total cash assets show a generally volatile pattern with notable spikes and troughs. Starting at $1,086 million in March 2018, cash decreased sharply through 2018, reaching a low of $502 million by the end of December 2018. A remarkable surge occurred in the second quarter of 2019, peaking at $2,430 million, followed by a decline to under $600 million by the end of 2019. In 2020, cash assets increased substantially, reaching the highest level of $6,588 million in the third quarter, before falling sharply towards the end of 2020. The subsequent year shows moderate fluctuations, with cash assets generally ranging between $1,000 million and $2,300 million, culminating in $2,371 million in the first quarter of 2022.
- Current Liabilities
- Current liabilities exhibit a somewhat elevated but variable trend. During 2018, liabilities fluctuated around the $7,000 million mark, peaking at $10,531 million in the first quarter of 2019. They then decreased over the following two quarters but increased again in the latter part of 2019. The year 2020 saw a significant rise in liabilities, reaching a maximum of $14,379 million in the third quarter, before declining substantially by the end of the year to $8,704 million. From 2021 into early 2022, liabilities remained relatively stable between approximately $8,600 million and $10,500 million, with no clear upward or downward trend.
- Cash Ratio
- The cash ratio, which measures the company's ability to cover current liabilities with cash assets alone, reflects the fluctuations seen in cash and liabilities. The ratio was relatively low throughout 2018, oscillating between 0.05 and 0.15, indicating limited cash coverage. It increased sharply in the second quarter of 2019 to 0.27, but then returned to lower levels around 0.08 by the end of that year. A significant improvement occurred during 2020, with the cash ratio rising to 0.36 in the second quarter and peaking at 0.46 in the third quarter, coinciding with the peak in cash assets. However, the ratio dropped off by the end of 2020, and remained modest through 2021, fluctuating mainly between 0.11 and 0.15, before increasing somewhat to 0.23 in the first quarter of 2022.
Overall, the analysis suggests that the company experienced considerable volatility in its liquidity position over the observed period. Periods of strong cash accumulation in 2019 and mid-2020 were not consistently maintained, leading to fluctuating cash coverage relative to current liabilities. While current liabilities increased notably in 2020, the corresponding rise in cash assets helped improve liquidity metrics temporarily. The more recent periods show a stabilization trend but at lower liquidity ratios than during peak periods. Monitoring cash management and current liabilities remains essential to sustain adequate liquidity levels going forward.